stock
TXG · 10x Genomics, Inc.
What 10x Genomics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live TXG price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on TXG.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- Not reported.
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- 70.0%
- Operating
- -14.3%
- Net
- -12.2%
Returns
- ROE
- -9.1%
- ROA
- -7.3%
Health
- Current ratio
- 5.7x
- Debt/equity
- —
Deep value
- NCAV
- $470.15M
- NCAV per share
- —
- Price/NCAV
- Locked
- NNWC
- $359.96M
- NNWC per share
- —
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $151.04M | $112.50M | -$19.55M | -$17.93M | 10-Q filed 2026-08-07 |
| 2026-03-31 | $150.84M | $106.18M | -$17.05M | -$13.47M | 10-Q filed 2026-08-07 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $166.03M | $113.05M | -$19.54M | -$16.21M | DEF 14A filed 2026-04-24 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $149.00M | $100.31M | -$32.24M | -$27.47M | 10-Q filed 2025-11-07 |
| 2025-06-30 | $172.91M | $125.08M | $30.13M | $34.54M | 10-Q filed 2026-08-07 |
| 2025-03-31 | $154.88M | $105.44M | -$39.33M | -$34.36M | 10-Q filed 2026-08-07 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $165.02M | $110.95M | -$49.84M | -$49.00M | DEF 14A filed 2026-04-24 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $151.65M | $106.39M | -$41.48M | -$35.75M | 10-Q filed 2025-11-07 |
- Assets
- $1.03B
- Equity
- $825.55M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $642.82M | -$60.98M | -$43.50M | $130.12M |
| 2024-12-31 | $610.78M | -$194.56M | -$182.60M | -$5.73M |
| 2023-12-31 | $618.73M | -$265.33M | -$255.10M | -$63.80M |
| 2022-12-31 | $516.41M | -$167.94M | -$166.00M | -$165.27M |
| 2021-12-31 | $490.49M | -$52.25M | -$58.20M | -$122.65M |
| 2020-12-31 | $298.85M | -$534.14M | -$542.73M | -$254.56M |
| 2019-12-31 | $245.89M | -$30.57M | -$31.25M | -$8.12M |
| 2018-12-31 | $146.31M | -$110.76M | -$112.48M | -$82.69M |
| 2017-12-31 | $71.08M | -$18.38M | -$18.76M | -$14.46M |
Company filings
events
5% owners ()
T. Rowe Price Associates, Inc.
Passive stake
ARK Investment Management LLC
Stake update
Vanguard Capital Management
Passive stake
Vanguard Portfolio Management
Passive stake
The Vanguard Group
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
SULIMAN SHEHNAAZ
Director
Sale$464,668Sep 24, 4:30 PM ET
Saxonov Serge
Chief Executive Officer, Director
Sale$2,030,562Sep 24, 4:29 PM ET
Taich Adam
Chief Financial Officer
Sale$2,995,470Sep 11, 4:47 PM ET
STUELPNAGEL JOHN R
Director
Sale$1,235,072Sep 8, 7:00 PM ET
Saxonov Serge
Chief Executive Officer, Director
Sale$667,901Aug 28, 7:22 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- ARK Investment Management
Period Tue 30 Jun 2026
2.5%Trimmed - Duquesne Family Office
Period Tue 30 Jun 2026
0.3%New - Point72
Period Tue 30 Jun 2026
0.1%New - Bridgewater Associates
Period Tue 30 Jun 2026
0.0%Trimmed
News
Stories that named TXG, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about TXG.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on TXG come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the TXG board